ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 429 filers reported holding ENCOMPASS HEALTH CORP in Q1 2019. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $17,000 | -22.7% | 310 | +0.3% | 0.00% | -25.0% |
| Q1 2022 | $22,000 | +10.0% | 309 | +0.3% | 0.00% | +33.3% |
| Q4 2021 | $20,000 | -13.0% | 308 | +0.3% | 0.00% | -25.0% |
| Q3 2021 | $23,000 | -4.2% | 307 | +0.3% | 0.00% | 0.0% |
| Q2 2021 | $24,000 | -27.3% | 306 | -24.6% | 0.00% | -50.0% |
| Q1 2021 | $33,000 | 0.0% | 406 | +0.2% | 0.01% | 0.0% |
| Q4 2020 | $33,000 | +26.9% | 405 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $26,000 | -16.1% | 405 | -20.0% | 0.01% | -33.3% |
| Q2 2020 | $31,000 | -3.1% | 506 | +0.2% | 0.01% | -20.0% |
| Q1 2020 | $32,000 | -8.6% | 505 | 0.0% | 0.02% | +15.4% |
| Q4 2019 | $35,000 | +9.4% | 505 | -0.4% | 0.01% | -7.1% |
| Q3 2019 | $32,000 | 0.0% | 507 | -0.4% | 0.01% | 0.0% |
| Q2 2019 | $32,000 | +3100.0% | 509 | +4141.7% | 0.01% | +1300.0% |
| Q1 2019 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,000 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 697,659 | $45,334,000 | 10.13% |
| JANA PARTNERS LLC | 1,741,513 | $113,164,000 | 10.12% |
| Endurant Capital Management LP | 276,105 | $17,941,000 | 5.31% |
| REINHART PARTNERS, LLC. | 726,140 | $47,184,000 | 3.55% |
| Prosight Management, LP | 107,921 | $7,013,000 | 3.34% |
| Advantage Alpha Capital Partners LP | 160,234 | $10,412,000 | 2.41% |
| RK Capital | 115,800 | $7,525,000 | 2.13% |
| Copeland Capital Management, LLC | 700,015 | $45,487,000 | 2.02% |
| Sivik Global Healthcare LLC | 65,000 | $4,224,000 | 1.82% |
| Walthausen & Co., LLC | 120,016 | $7,799,000 | 1.62% |